Thomas Patrick Kelly

Companies

• Xenon PharmaceuticalsChief financial officer Oct 17, 2025 to now¹
• Deciphera Pharmaceuticals, Inc.Chief financial officer Sep 28, 2017 to Jun 11, 2024²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Xenon Pharmaceuticals XENE0 shares³Oct 17, 2025
• DPDeciphera Pharmaceuticals, Inc.0 shares⁴Jun 11, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 11, 2024U 42,478 shares of Deciphera Pharmaceuticals, Inc.⁴
• Jun 11, 2024Returned to company 72,029 shares of Deciphera Pharmaceuticals, Inc.⁴
• Jun 11, 2024Granted 34,157 shares of Deciphera Pharmaceuticals, Inc.⁴
• Feb 16, 2024Sold 3,010 shares at $15.62 of Deciphera Pharmaceuticals, Inc.⁵
• Feb 15, 2024Granted 17,275 shares of Deciphera Pharmaceuticals, Inc.⁵
• Jan 16, 2024Sold 2,435 shares at $14.47 of Deciphera Pharmaceuticals, Inc.⁶
• Dec 13, 2023Sold 2,792 shares at $15.37 of Deciphera Pharmaceuticals, Inc.⁷
• Dec 12, 2023Granted 8,244 shares of Deciphera Pharmaceuticals, Inc.⁷
• Oct 30, 2023Sold 2,316 shares at $12.02 of Deciphera Pharmaceuticals, Inc.⁸
• Oct 28, 2023Granted 8,244 shares of Deciphera Pharmaceuticals, Inc.⁸
• Jun 16, 2023Sold 1,655 shares at $14.40 of Deciphera Pharmaceuticals, Inc.⁹
• Feb 16, 2023Sold 1,370 shares at $15.10 of Deciphera Pharmaceuticals, Inc.¹⁰
• Feb 15, 2023Granted 16,488 shares of Deciphera Pharmaceuticals, Inc.¹⁰
• Jan 17, 2023Sold 2,403 shares at $21.24 of Deciphera Pharmaceuticals, Inc.¹¹
• Jun 16, 2022Sold 1,768 shares at $10.75 of Deciphera Pharmaceuticals, Inc.¹²
• Feb 16, 2022Sold 1,368 shares at $9.05 of Deciphera Pharmaceuticals, Inc.¹³
• Jan 18, 2022Granted 20,500 shares of Deciphera Pharmaceuticals, Inc.¹⁴
• Dec 15, 2021Granted 11,100 shares of Deciphera Pharmaceuticals, Inc.¹⁵